Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Alerts, recalls and safety information: medicines and medical devices
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Product information about medicines
- Medical devices regulation and safety
- Latest information for patients
- MHRA guidance on coronavirus (COVID-19)
- About MHRA
- All MHRA services and information
Featured
Givinostat conditionally approved to treat patients with Duchenne muscular dystrophy (DMD)
Press release
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (20 December 2024) granted a conditional marketing authorisation for the medicine givinostat (Duvyzat) to treat Duchenne muscular dystrophy (DMD).
The amended regulatory framework will speed up trial approvals and encourage innovation in trial design without compromising patient safety
Medicines and medical devices: Six tips for staying healthy and safe this festive season
Press release
From coughs and sneezes to mental health apps, these tips from the MHRA will help you stay safe during the festive season and beyond
Delgocitinib approved to treat adult patients with moderate to severe chronic hand eczema
News story
The Medicines and Healthcare products Regulatory Agency has approved the medicine delgocitinib (Anzupgo) to treat moderate to severe chronic hand eczema in adults when topical corticosteroids are inadequate or inappropriate.
MHRA trials five innovative AI technologies as part of pilot scheme to change regulatory approach
Press release
The pilot scheme, AI Airlock, is designed to help test and improve the rules for AI-powered medical devices to ensure they reach patients quickly, safely and effectively.
The MHRA issues final call to comply with Windsor Framework arrangements for medicines from January 2025
Press release
With industry already showing a very high level of readiness, the MHRA is reminding remaining marketing authorisation holders to ensure they are prepared for the new packaging and labelling measures
Latest from the Medicines and Healthcare products Regulatory Agency
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Transparency and freedom of information releases
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA10 South Colonnade
London
E14 4PU
United Kingdom
Telephone (including out of hours):
020 3080 7651
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom